WI
CVS icon

Wafra Inc’s CVS Health CVS Stock Holding History

Wafra Inc’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-215,135
Closed -$20.5M – 70
2022
Q3 		$20.5M Buy
+215,135
New +$21.3M 0.81% 45
2021
Q3 		– Sell
-659,203
Closed -$55M – 73
2021
Q2 		$55M Hold
659,203
– – 2.07% 19
2021
Q1 		$49.6M Buy
659,203
+86,256
+15% +$6.28M 2.06% 20
2020
Q4 		$39.1M Buy
572,947
+179,792
+46% +$11.7M 1.75% 22
2020
Q3 		$23M Hold
393,155
– – 1.3% 35
2020
Q2 		$25.5M Buy
393,155
+83,168
+27% +$5.24M 1.62% 22
2020
Q1 		$18.4M Buy
309,987
+167,559
+118% +$11.2M 1.41% 34
2019
Q4 		$10.6M Buy
+142,428
New +$10M 0.65% 54
2019
Q1 		– Sell
-184,755
Closed -$12.1M – 81
2018
Q4 		$12.1M Buy
+184,755
New +$13.8M 0.47% 39
2017
Q4 		– Sell
-6,302
Closed -$512K – 92
2017
Q3 		$512K Hold
6,302
– – 0.02% 87
2017
Q2 		$507K Buy
+6,302
New +$498K 0.03% 88
2016
Q3 		– Sell
-165,228
Closed -$15.8M – 79
2016
Q2 		$15.8M Sell
165,228
-38,459
-19% -$3.83M 1.93% 22
2016
Q1 		$21.1M Hold
203,687
– – 2.4% 11
2015
Q4 		$19.9M Sell
203,687
-82,739
-29% -$8.1M 2.31% 16
2015
Q3 		$27.6M Sell
286,426
-5,910
-2% -$621K 3.4% 2
2015
Q2 		$30.7M Buy
292,336
+6,201
+2% +$634K 3.33% 3
2015
Q1 		$29.5M Hold
286,135
– – 3.1% 3
2014
Q4 		$27.6M Buy
286,135
+10,320
+4% +$909K 2.85% 4
2014
Q3 		$22M Buy
275,815
+37,620
+16% +$2.97M 2.55% 7
2014
Q2 		$18M Sell
238,195
-7,000
-3% -$529K 2.24% 9
2014
Q1 		$18.4M Buy
245,195
+18,600
+8% +$1.31M 2.22% 12
2013
Q4 		$16.2M Hold
226,595
– – 2.07% 13
2013
Q3 		$12.9M Hold
226,595
– – 1.87% 19
2013
Q2 		$13M Buy
+226,595
New +$13.1M 2.06% 16

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wafra Inc's CVS Position: Q4 2022 in Review

Wafra Inc sold out of CVS Health (CVS) in Q4 2022, closing a stake of 215,135 shares — an estimated $20.5M sold.

Wafra Inc first reported a position in CVS in Q2 2013 and held it in 24 quarters. The position peaked at $55M in Q2 2021. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Wafra Inc reported no remaining CVS Health position as of Q4 2022 after selling out during the quarter.
  • Wafra Inc sold 215,135 CVS Health shares in Q4 2022, an estimated $20.5M.
  • Wafra Inc first reported a position in CVS Health in Q2 2013 and held it in 24 quarters.
  • Wafra Inc's CVS Health position peaked at $55M in Q2 2021.
  • 2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Wafra Inc's 13F filing for Q4 2022, filed 31 Jan 2023.